# Tenet Healthcare COO Reports Equity Grants and Tax Trades > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/tenet-healthcare-coo-equity-grants-tax-trades-sec-filing/ > **Published:** 2026-04-24T15:03:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:03:07-04:00 > **Clinical Summary:** Explore Tenet Healthcare COO equity grants and tax trades detailed in the latest SEC filing, highlighting executive compensation insights. --- ✦ New CED Clinical Relevance** #50 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyIndustry Clinical Perspective ⚠️ While this SEC filing regarding Tenet Healthcare’s executive compensation practices may seem removed from direct clinical care, healthcare administrators’ financial incentives and equity holdings can influence institutional policies affecting cannabis-related [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions, particularly around drug screening protocols, [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) pathways, and employee wellness programs. The complexity here lies in distinguishing between legitimate business governance and potential conflicts of interest that might inadvertently shape clinical guidelines or resource allocation in ways that affect patient access to evidence-based [cannabis therapies](https://cedclinic.com/deep-reading-decline-digital-age-insights/) where indicated. Clinicians should recognize that institutional policies around cannabis may reflect administrative and financial considerations beyond purely clinical evidence, while acknowledging that fiduciary responsibility to shareholders is a real and legitimate institutional constraint. Understanding these organizational pressures can help providers advocate more effectively for patients within their institutional structures and remain alert to whether formulary decisions or screening policies are evidence-based or administratively driven. The practical takeaway is that clinicians engaged in cannabis discussions with patients should be aware 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Tenet+Healthcare+COO+reports+equity+grants+and+tax+trades+%7C+%3Cb%3ETHC%3C%2Fb%3E+SEC+Filing+-+Stock+Titan+%40drcaplan&url=https%3A%2F%2Fstocktitan.net%2Fsec-filings%2FTHC%2Fform-4-tenet-healthcare-corp-insider-trading-activity-4250fe69426f.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fstocktitan.net%2Fsec-filings%2FTHC%2Fform-4-tenet-healthcare-corp-insider-trading-activity-4250fe69426f.html)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Tenet+Healthcare+COO+reports+equity+grants+and+tax+trades+%7C+%3Cb%3ETHC%3C%2Fb%3E+SEC+Filing+-+Stock+Titan+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fstocktitan.net%2Fsec-filings%2FTHC%2Fform-4-tenet-healthcare-corp-insider-trading-activity-4250fe69426f.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Proposed sale of 24000 shares reported | THC** SEC Filing – Form 144 – Stock Titan](https://cedclinic.com/thc-sec-filing-form-144-proposed-sale-24000-shares/) - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) 📰 Source: [https://stocktitan.net/sec-filings/THC/form-4-tenet-healthcare-corp-insider-trading-activity-4250fe69426f.html](https://stocktitan.net/sec-filings/THC/form-4-tenet-healthcare-corp-insider-trading-activity-4250fe69426f.html) Further Reading CED Clinic Blog[Cannabinoids and Chronic Pain: 2025 Evidence Review](https://cedclinic.com/cannabinoids-chronic-pain-clinical-outcomes-2025/) Evidence Watch[Mechanistic Pathways Linking Cannabidiol, Hemp Seed Oil and Black Sesame Oil in Hyperarousal Insomnia: A Narrative Review.](https://cedclinic.com/mechanistic-pathways-insomnia-cbd-hemp-sesame-oil/) Research Digest[Research Digest: 10 Recent Studies – April 22, 2026](https://cedclinic.com/recent-cannabinoid-clinical-research-april-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know](https://cedclinic.com/tenet-healthcare-revvity-avantor-azenta-and-elanco-shares-plummet-what-you-need-to-know/) A detailed analysis of recent stock performance declines affecting Tenet Healthcare and other major companies, providing context for investors. [Read More](https://cedclinic.com/tenet-healthcare-revvity-avantor-azenta-and-elanco-shares-plummet-what-you-need-to-know/) 12 Best Alcohol Stocks to Buy Right Now – Insider Monkey Explore top alcohol stocks recommended for investment, offering insights into market trends and financial outlooks. Explore Stocks [The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) An informative guide on leading [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) that support immune health and resilience, relevant for wellness-focused consumers. [Learn More](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).